SCHEMBL25663240

SCHEMBL25663240

c1ccc2cc(-c3ccc(N(c4ccc(-c5ccc6ccccc6c5)cc4)c4ccc(-c5cc6sc7ccccc7c6cn5)cc4)cc3)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ CYP11B1 P15538 3/20 0.34
▸ CYP11B2 P19099 2/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ TDO2 P48775 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ HTR5A P47898 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24055536 0.98 IDO1 (0.38) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663242 0.96 RAB9A (0.34) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL26833747 0.93 IDO1 (0.34) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663239 0.93 IDO1 (0.35) ALDH1A1HPGDRAB9ANPC1CYP11B1
SCHEMBL25663233 0.90 ALDH1A1 (0.39) ALDH1A1HPGDRAB9ACYP11B1IDO1
SCHEMBL24055857 0.89 GPR3 (0.38) ALDH1A1HPGDRAB9ANPC1CYP11B1
SCHEMBL24055542 0.88 GABRP (0.37) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL25663238 0.88 ALDH1A1 (0.37) ALDH1A1HPGDRAB9ACYP11B1IDO1
SCHEMBL24057707 0.87 GABRP (0.36) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19
SCHEMBL26423979 0.87 NPC1 (0.38) ALDH1A1CYP1A2HPGDCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 ALDH1A1 3072/4885CYP1A2 336/4885HPGD 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback